Hydromet (Hydrocodone Bitartrate / Homatropine Methylbromide) - Summary

HYDROMET SUMMARY

HYDROCODONE BITARTRATE AND

This product contains hydrocodone (dihydrocodeinone) bitartrate, a semisynthetic centrally acting narcotic antitussive. Homatropine methylbromide is included in a subtherapeutic amount to discourage deliberate overdosage. Each 5 mL (one teaspoonful) contains:

Hydrocodone Bitartrate........................ 5 mg

Homatropine Methylbromide............... 1 . 5 mg

Hydromet (hydrocodone/homatropine) is indicated for the following:

For the symptomatic relief of cough.

See all Hydromet indications & dosage >>

NEWS HIGHLIGHTS

Media Articles Related to Hydromet (Hydrocodone / Homatropine)

Whooping Cough Cases Rise as Parents Opt Out of Vaccine
Source: MedicineNet Chickenpox (Varicella) Specialty [2013.06.03]
Title: Whooping Cough Cases Rise as Parents Opt Out of Vaccine
Category: Health News
Created: 6/3/2013 10:35:00 AM
Last Editorial Review: 6/3/2013 12:00:00 AM

Study: Older Whooping Cough Vaccine More Effective
Source: MedicineNet Pertussis Specialty [2013.05.20]
Title: Study: Older Whooping Cough Vaccine More Effective
Category: Health News
Created: 5/20/2013 10:35:00 AM
Last Editorial Review: 5/20/2013 12:00:00 AM

More Evidence Whooping Cough Protection Wanes
Source: MedicineNet Pertussis Specialty [2013.03.11]
Title: More Evidence Whooping Cough Protection Wanes
Category: Health News
Created: 3/11/2013 10:35:00 AM
Last Editorial Review: 3/11/2013 12:00:00 AM

Health Tip: Protecting Babies From Whooping Cough
Source: MedicineNet Pertussis Specialty [2013.02.27]
Title: Health Tip: Protecting Babies From Whooping Cough
Category: Health News
Created: 2/27/2013 8:35:00 AM
Last Editorial Review: 2/27/2013 12:00:00 AM

Whooping Cough Symptoms
Source: MedicineNet Chronic Cough Specialty [2013.02.20]
Title: Whooping Cough Symptoms
Category: Doctor's & Expert's views on Symptoms
Created: 2/20/2013 4:36:00 PM
Last Editorial Review: 2/20/2013 4:36:31 PM

more news >>

Published Studies Related to Hydromet (Hydrocodone / Homatropine)

Characterizing the subjective, psychomotor, and physiological effects of a hydrocodone combination product (Hycodan) in non-drug-abusing volunteers. [2003.01]
RATIONALE: The subjective, psychomotor, and physiological effects of prescription compounds containing the opioid hydrocodone have not been studied in a population of non-drug-abusing people who might be prescribed these compounds for cough or pain relief. OBJECTIVES: To characterize the effects of a hydrocodone combination product, Hycodan, which contains hydrocodone and a peripherally-acting anticholinergic, homatropine, in non-drug-abusing volunteers... CONCLUSIONS: Hycodan at the highest dose tested had effects similar to that of a prototypic mu agonist, morphine. Both drugs produced pleasant (including drug liking) as well as unpleasant subjective effects. Post-session ratings of overall liking and "want to take drug again" were not significant.

more studies >>

Clinical Trials Related to Hydromet (Hydrocodone / Homatropine)

Pharmacokinetics and Bioequivalence of Vycavert (10 mg Hydrocodone Bitartrate/325 mg Acetaminophen) Compared to the Reference Drug Norco [Recruiting]
This study aims to determine whether the hydrocodone and acetaminophen exposures following oral dosing of Vycavert are comparable to those following oral dosing of Norco.

A Study to Evaluate the Pharmacokinetics of the Hydrocodone Extended-Release Tablet (CEP-33237) in Subjects With Normal Hepatic Function and Subjects With Moderate Hepatic Impairment [Recruiting]
The purpose of this study is:

1. To assess the pharmacokinetics of the hydrocodone bitartrate extended-release tablet in subjects with moderate hepatic impairment and in subjects with normal hepatic function.

2. To assess the safety and tolerability of the hydrocodone bitartrate extended-release tablet in subjects with moderate hepatic impairment and in subjects with normal hepatic function.

A Crossover Study to Assess the Bioequivalence of Hydrocodone Bitartrate Extended-Release Tablet [Recruiting]
The primary objective of this study is to assess the bioequivalence of two 45-mg hydrocodone bitartrate extended-release tablets and one 90-mg hydrocodone bitartrate extended-release tablet.

Efficacy and Safety of Hydrocodone Bitartrate (HYD) in Subjects With Moderate to Severe Chronic Low Back Pain [Recruiting]
The primary objective of this study is to evaluate the analgesic efficacy and safety of HYD tablets 20 to 120 mg once-daily dose compared to placebo in subjects with moderate to severe chronic low back pain uncontrolled by their current stable analgesic regimen

Hydrocodone For Pain Control in First Trimester Surgical Abortion [Recruiting]
The purpose of this study is to determine whether preoperatively administered hydrocodone/acetaminophen (HC/APAP) reduces pain during a first trimester surgical abortion.

more trials >>